There are very many reasons to be thankful for the unique level of healthcare offered free by the NHS in Britain. In America insulin manufacturers have cynically hiked their prices in recent years, meaning insulin can cost almost £800 for a month’s supply. One in four Americans with insulin dependent diabetes routinely skip or ration their insulin, and deaths are common. Now JDRF, the Juvenile Diabetes Research Foundation, is supporting a joint project with a pharmaceutical company called Civica to manufacture and distribute three low-cost biosimilar insulin options to enable anyone to purchase insulin at no more than $30 (£23) per vial and $55 (£42) for a box of five pens, regardless of insurance status. Unfortunately, this initiative will not come on stream until 2024, meaning many more people will die in the meantime. For more CLICK HERE
Menu
